Excited for the second session of Day 2 of #AACECVMET where Ralph A. DeFronzo, BMS, MD, MS, BS (@UTHealthSA) talks about "SGLT2 Inhibitors and GLP-1 RAs: Cardio-Renal Metabolic Drugs for the Ages", moderated by Joseph A. Vassalotti, MD (@Joe_Vassalotti) #EndoTwitter #diabetes @UTHealthSA @Joe_Vassalotti Ominous Octet for hyperglycemia: increased lipolysis, increased glucose reabsorption (kidney), decreased glucose uptake (muscle), neutrotransmitter dysfunction, increased HGP (liver), increased glucagon secretion, decreased insulin secretion, decreased incretin effect #AACECVMET

Day 2 of #AACECVMET starts with "Protecting Our Patients: Implementing Immunization Recommendations Within a Culture of Vaccine Confidence" by Kenneth Izuora, MD, MBA, FACE, moderated by Betul Hatipoglu, MD @TheAACE #AACE #EndoTwitter @TheAACE During flu seasons, influenza vaccinations reduce all-cause mortality in adult patients with type 2 diabetes by 50% #AACECVMET #MedTwitter #AACE

Up next is "Healthcare Disparities in Cardiovascular Disease: Social and Nutrition Deserts" by Joshua J. Joseph, MD, MPH, FAHA (@joshuajosephmd), moderated by S. Sethu K. Reddy, MD (@endocrineguru) at #AACECVMET #AACE #Endotwitter @joshuajosephmd @endocrineguru There are higher rates of diabetes mortality (2-fold death disparity) in rural areas as compared to urban areas, and a higher mortality in Black patients compared to White patients. #AACECVMET #AACE #HealthDisparities

The first afternoon session at #AACECVMET is "Endocrine Hypertension and Cardiovascular Effects" by Richard Auchus, MD, PhD, FACE (@EndocrinologyM), moderated by L. Maria Belalcazar, MD, FACE (@utmbhealth)! #EndoTwitter #WeAreAACE @EndocrinologyM @utmbhealth Pheochromocytoma Cardiovascular & Metabolic complications include commonly tachycardia & HTN, but also MI, ventricular rupture, catecholamine cardiomyopathy, hemorrhagic stroke, aortic dissection, and hyperglycemia+fatty liver+ weight loss together! #AACECVMET #Endotwitter

Session 2 of #AACECVMET that I'm attending is "Nonalcoholic Fatty Liver Disease: The Global Pandemic" by Dr. Scott Isaacs, MD (@EmoryMedicine)! #WeAreAACE @EmoryMedicine Pathogenic drivers of NAFLD: genetics, epigenetics, dysbiosis, dysfunctional adipose tissue, insulin resistance, and calorie excess #AACECVMET

Kicking off Day 1 of @TheAACE Cardiometabolic Conference with "AACE Guideline Update: Developing a Diabetes Mellitus Comprehensive Care Plan" by Lawrence Blonde, MD (Ochsner Medical Center), moderated by S. Sethu K. Reddy, MD (CMU College of Medicine) #WeAreAACE #EndoTwitter @TheAACE Grade B rec: Artificial intelligence systems, authorized by the FDA for detecting greater than mild diabetic retinopathy, can be used as an alternative to traditional screening approaches...facilitate diagnosis of vision-threatening retinopathy #AACE #Diabetes